J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Anim Sci. 2008. 86:3110-3124. doi:10.2527/jas.2008-1075
© 2008 American Society of Animal Science

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jas.2008-1075v1
86/11/3110    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchant-Forde, J. N.
Right arrow Articles by Richert, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchant-Forde, J. N.
Right arrow Articles by Richert, B. T.

ANIMAL PRODUCTION

The effects of R-salbutamol on behavior and physiology of finishing pigs1,2

J. N. Marchant-Forde*,3, D. C. Lay, Jr.*, R. M. Marchant-Forde*,4, K. A. McMunn* and B. T. Richert{dagger}

* USDA-ARS, Livestock Behavior Research Unit, Purdue University, West Lafayette, IN 47907 {dagger} Department of Animal Sciences, Purdue University, West Lafayette, IN 47907


    Abstract
 Top
 Abstract
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Salbutamol has potential for use as a repartioning agent in swine. The aims of this experiment were to determine effects of salbutamol on behavior and physiology of finishing pigs. The study used 192 pigs (88.8 ± 0.9 kg of BW) housed in groups of 6 in 32 pens and assigned to 1 of 4 treatments: 1) control—0 mg/kg of salbutamol, 2) 2R—control diet with 2 mg/kg of the pure R-enantiomer of salbutamol, 3) 4R—control diet with 4 mg/kg of pure R-salbutamol, or 4) 8RS—control diet with 8 mg/kg of a 50:50 mixture of the R- and S-enantiomers. All diets were offered ad libitum for 4 wk. Salbutamol diets were replaced with control diets 24 to 48 h before slaughter. Behavioral responses to handling during weighing were recorded immediately before assignment to the treatments (wk 0) and at weekly intervals over the next 4-wk period. Behavioral and heart rate (HR) responses to a 10-min human presence test in the home pen were measured during wk 0, wk 1, and wk 3. Heart rate responses to a 36-min transportation were recorded. One pig from each pen had blood collected 4 times: during wk 0, 2, 4, and at exsanguination. Blood was analyzed for NEFA, creatine kinase, glucose, lactate, blood urea nitrogen, ammonia, insulin, cortisol, norepinephrine, and epinephrine. Data were analyzed using PROC GLM of SAS, with pen as the experimental unit. Treatment had no effect on time spent lying laterally, overall activity, or time spent alert. Treatment had no effect on handling measures (P > 0.05) or on behavioral responses to human presence (P > 0.05), with all pigs willing to spend similar amounts of time close to and touching the human. However, during the human presence test in wk 1 and wk 3, control pigs had HR around 10 peats per minute less (P < 0.05) than pigs in the other 3 treatments. During transport, overall HR were similar across treatments (P > 0.05). However, at certain 1-min time points, control pigs had greater HR than salbutamol-treated pigs (P < 0.05). There were no treatment differences in lactate, epinephrine, or norepinephrine concentrations at any point. During wk 4, control pigs had less creatine kinase (P < 0.02) and greater blood urea nitrogen (P < 0.005) compared with pigs fed all the salbutamol treatments. The home pen behavior, handling, human presence test, and transport results indicate that salbutamol-treated pigs do not show marked differences in home pen time budgets and behavioral and HR responses to handling and transportation compared with control pigs. Thus, salbutamol did not have a negative effect on finishing pig well-being during this study.

Key Words: behavior • husbandry • physiology • pig • salbutamol


    INTRODUCTION
 Top
 Abstract
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Over the last 2 decades, much research has been carried out on repartitioning agents. Most work has concentrated on β-agonists, such as clenbuterol (Ricks et al., 1984Go), cimaterol (Moser et al., 1986Go), and ractopamine (Watkins et al., 1990Go). Consumers demand lean meat that is wholly safe, and, in some markets, there is also strong demand for a product that meets certain animal well-being criteria. Concerns about the potential side-effects of drug administration on the animals (Hill and Dalrymple, 1987Go) and of possible dangers of drug residues for consumers (Salleras et al., 1995Go) has meant that approval for use of β-agonists in commercial production has taken many years.

Ractopamine HCl was approved for use in pigs by the US Food and Drug Administration in 1999. It has been shown to improve ADG, G:F, carcass yield, and carcass lean content (Gu et al., 1991aGo,bGo), but it has a short-term benefit, with the greatest response during the first 14 d of administration (Williams et al., 1994Go; Schinckel et al., 2003Go). It is recommended for use over a 4-wk period before slaughter. However, ractopamine has been shown to make pigs harder to handle and have elevated circulating catecholamine concentrations and greater heart rates (Marchant-Forde et al., 2003Go). They also have an increased risk of becoming fatigued during handling (FDA, 2002Go).

There would therefore appear to be a need for a repartitioning agent that does not have any human or animal health concerns. Salbutamol is a widely prescribed human pharmaceutical, having an established safety record worldwide, and evidence suggests that it has a repartitioning effect (Oksbjerg et al., 1996Go; Hansen et al., 1997Go). However, in addition to demonstrating positive production benefits, it is also important that the negative animal well-being effects observed with other compounds are absent or greatly decreased. The objective of this study was to evaluate the effects of the pure, single-enantiomer R-salbutamol and a racemic mixture of R- and S-enantiomer salbutamol on finishing pig behavior and physiology.


    MATERIALS AND METHODS
 Top
 Abstract
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Animals were housed in accordance with FASS (1999)Go guidelines, and the project was approved by the Purdue Animal Care and Use Committee.

Animals, Housing, and Husbandry

A total of 96 gilts and 96 barrows were used, offspring of PIC 280 sires on Danbred Yorkshire x Landrace gilts. They arrived in a group of 400 animals at the Purdue Animal Sciences Research & Education Center at weaning age (average 15.3 d), having come from a commercial farm in northern Kentucky with a journey time of 5 h. On arrival at the Purdue University Swine Evaluation Unit, approximately 350 animals were ear-tagged with individual numbers and randomly assigned to 1 of 12 identical pens with covered lying area and outdoor concrete-floored runs (14.0 m x 2.5 m). They were maintained on a standard commercial grower diet with access ad libitum. Ten days before the beginning of the experiment, about 300 of the pigs were weighed and 192 pigs were selected on the basis of the proposed target BW at the beginning of the imposed dietary treatments (88.8 kg). Selected pigs were blocked by BW and sex into 2 rows of 16 adjacent pens separated by a central corridor in 1 wing of the Swine Evaluation Unit, with 8 pens coming on trial per week for 4 successive weeks. Each pen (4.1 m x 1.4 m) housed 6 pigs and had fully slatted floors (the rear 2/3 being concrete slats, the front 1/3 being plastic-coated expanded metal). A single partition-mounted drinker was situated toward the rear of the pen, and a single-space feeder was situated at the front of each pen. Both water and feed were available ad libitum. The room was maintained at a minimum temperature of 18.5°C and naturally ventilated above the minimum level with air going through a heat exchanger.

As the blocks of pigs reached the proposed target BW, 1 pen of gilts and 1 pen of barrows were randomly assigned within block to 1 of 4 dietary treatments, which were fed over the final 4 wk before slaughter (d 0 to 28):

  1. CTL—finishing feed alone (CP 18.3%, lysine 1.1%, 3,534 kcal of ME/kg).
  2. 2R—finishing feed plus R-salbutamol (2 mg/kg—CP 18.3%, lysine 1.1%, 3,534 kcal of ME/kg).
  3. 4R—finishing feed plus R-salbutamol (4 mg/kg—CP 18.3%, lysine 1.1%, 3,534 kcal of ME/kg).
  4. 8RS—finishing feed plus 50:50 mix of RS salbutamol (8 mg/kg—CP 18.3%, lysine 1.1%, 3,534 kcal of ME/kg).

The major constituents of the diets are shown in Table 1Go.


View this table:
[in this window]
[in a new window]

 
Table 1. Ingredient identity and percentage contained in the 4 experimental diets, as-fed basis
 
At the end of the study period, pigs were loaded onto a flatbed truck and transported to the slaughter facility at the Purdue University West Lafayette campus (a distance of approximately 12.5 km, with a 5-min loading period, a 26-min transport period, and a 5-min unloading period). At the abattoir facility, they were offloaded and held in lairage for up to 1 h before slaughter. Each block of 8 pens was slaughtered over 2 separate days (Tuesday and Thursday), and blocks were slaughtered on successive weeks. Pigs assigned for slaughter on Tuesdays were withdrawn from supplemental diets 24 h before slaughter. Pigs assigned for slaughter on Thursdays were withdrawn from supplemental diets 48 h before slaughter. Pens of barrows and gilts were assigned to both withdrawal regimens over the 4 slaughter weeks. The transportation and slaughter process was subject to some constraints imposed by use of experimental drugs. Because control animals were entering the food chain and the treated animals were not, all control animals had to pass through the kill line first to prevent any contamination. Thus, the first truck on each day consisted of all 6 control animals plus 2 animals from each of the other 3 treatments. Also, this first truck made another stop on the farm after loading, to load a single animal on another experiment that was also entering the food chain. The second truck on each day consisted of 4 animals from each of the 3 salbutamol treatments and traveled direct from the Swine Evaluation Unit to the slaughter facility.

Animal Data Collection

Behavior in Home Pen Behavior of all pigs in all 32 pens (8 per treatment) was recorded using ceiling-mounted cameras (Panasonic WV-CD110AE, Matsushita Electric Industrial Co. Ltd., Osaka, Japan) attached to time-lapse video-recorders (Panasonic AG6720A, Matsushita Electric Industrial Co. Ltd.) over a 24-h period, once during the week before imposition of dietary treatments and also weekly during dietary treatment (wk 1, 2, and 4). The video data were analyzed using a scan-sampling technique, with behavior, location, and posture of each pig in a pen recorded every 10 min using the ethogram presented in Table 2Go. Data from each pig were then combined to give a behavioral time budget with each pen being an experimental unit. Video data were also analyzed to determine the amount of agonistic interactions using all-occurrences sampling.


View this table:
[in this window]
[in a new window]

 
Table 2. Ethogram used for recording time budget behavior in the home pen for pigs on all 4 treatments
 
Behavior During Handling All pigs were weighed weekly for a total of 5 times. Weighing was carried out in the central corridor by 2 from a pool of 3 handlers, who were blind to the treatments. Barriers were placed across the corridor between 10 and 20 m apart, forming a long, narrow pen. A walk-over weighing platform was situated in the center of the pen. The door to the home pen of the pigs was opened, and pigs were allowed to exit voluntarily for 20 s, if they desired. After 20 s, the handler entered the pen and herded any remaining pigs out into the corridor. Once in the corridor, all pigs were herded away from the home pen, across the weigh platform as a group. Once all pigs were across the platform, an individual pig was randomly selected and driven by 1 handler back toward the weighing platform in the direction of the home pen, using a solid board as a guide and hands and legs to push, where necessary. The other handler stood to the side of the platform and held the pig stationary for weighing, by use of a solid board. Once the BW was taken, the pig was allowed to continue moving across the platform. Once all 6 pigs had been weighed, pigs were herded back into the home pen by both handlers, and the gate was shut. The weighing process was videotaped using a hand-held camcorder, for later analysis by a skilled observer. The observer was blind to the treatments. The measures taken over the weighing are shown in Table 3Go


View this table:
[in this window]
[in a new window]

 
Table 3. Description of measures recorded during handling and weighing
 
Human Presence Test—Heart Rate and Behavior Heart rate responses to human presence were measured in all pens once during the week before imposition of dietary treatments (wk 0) and also once during wk 1 and 3 of the dietary imposition period. Sixteen pens of pigs were recorded on each of 2 afternoons (Tuesdays and Thursdays). The human entered each pen and fitted 3 of the 6 pigs with a Polar S810 (Polar Electro Oy, Kempele, Finland) heart rate (HR) monitor (see Marchant et al., 1995Go for methodology) set to record and store successive interbeat intervals. In each pen, pigs to be recorded were the heaviest and lightest pigs and a middle weight pig, based on BW at allocation. Once the last monitor of the pig had been fitted, all monitors were started, and the experimenter stood in a corner of the pen and allowed the pigs to interact with him, while recording 1-min scan samples of the behavior of all pigs in the pen using the ethogram described in Table 4Go. The interactions took the form of reaching out and stroking and scratching any of the pigs that approached. The test was carried out for 10 min from the time that the last monitor in the pen was started. At the end of this period, the experimenter removed the equipment and repeated the procedure in the other pens. After each set of 4 pens, HR data were downloaded from the receivers onto a personal computer. The data were displayed in graphical and numerical form using Polar Precision Performance Analysis Software (Version 3.02.007, Polar Electro Oy, Kempele, Finland) and were analyzed to determine mean HR every 1 min over the 10-min period, in beats per minute (bpm), with each pen as an experimental unit.


View this table:
[in this window]
[in a new window]

 
Table 4. Ethogram used for recording behavior during human presence test for pigs on all 4 treatments
 
Blood Physiology Blood samples were taken from a single, middle-weighted pig in each pen 3 times, once during the week before imposition of dietary treatments (wk 0) and also once during wk 2 and 4 of the dietary imposition period. This pig was chosen on the basis of BW when assigned to the pen and was not one of those chosen for HR monitoring. The blood was analyzed for catecholamines, cortisol, lactate, insulin, glucose, creatine kinase (CK), NEFA, blood urea nitrogen (BUN), and ammonia. Sixteen pigs per week had blood samples taken on Wednesdays. During sampling, 2 experimenters entered the pen, and the pig was restrained by 1 experimenter using a nose snare while the other experimenter took two 10-mL blood samples by jugular venipuncture. An additional postslaughter blood sample was taken from the same pigs during exsanguination, and this was analyzed for all compounds except catecholamines. Blood was collected into 1 EDTA-treated tube and 1 heparin-treated tube and immediately stored on ice. Once collecting for that day was complete, blood samples were then immediately centrifuged at 700 x g for 15 min at 4°C and plasma aliquots stored at –80°C until further analysis.

For plasma catecholamine analysis, samples were acidified and deproteinized with 4 M perchloric acid, and a commercial alumina-based solid phase extraction kit (ESA Inc., Chelmsford, MA) was used to extract catecholamines from the plasma. After extraction and injection onto the reverse-phase column, norepinephrine and epinephrine were detected using HPLC with electrochemical detection. All assays were done in 2 runs. The interassay CV for norepinephrine and epinephrine were 11.5 and 20.2%, respectively.

Plasma cortisol was measured using a competitive binding RIA (GammaCoat, DiaSorin, Stillwater, MN). The concentration of cortisol was calculated from a reference curve that ranged from 0 ng/mL (99.6% binding) to 600 ng/mL (17.6% binding) and a correlation coefficient of 0.99. All cortisol assays were done in a single batch, and the intraassay CV was 3.2%.

Plasma lactate was measured using a nonradioactive colorimetric assay kit (State University of New York, Buffalo) based on the reduction of 2-p-iodophenyl-3-p-nitrophenyl-5-phenyl tetrazolium chloride in a NADH-coupled enzymatic reaction to formazan, which is water-soluble and exhibits an absorption maximum at 492 nm. Because the intensity of the red color formed was proportional to the lactate concentration, the assay, using a set of lactate standards, measured the concentration of lactate released to the culture medium or circulation in a semiquantitative manner. All lactate assays were done in a single batch, and the intraassay CV was 14.1%.

Blood urea nitrogen, glucose, CK, and ammonia were measured on an IDEXX VetTest Chemistry Analyzer (IDEXX Laboratories, Westbrook, ME). Samples for analysis of CK were diluted up to 1:6 in normal saline, as per instructions of the manufacturer, to fall within the accurate detection range of the machine.

Plasma insulin was measured using a solid-phase RIA kit (Coat-A-Count Insulin, Siemens Medical Solutions Diagnostics, Los Angeles, CA). The concentration of insulin was calculated from a reference curve. All insulin assays were done in a single batch, and the intraassay CV was 3.1%. Nonesterified fatty acids were measured using an in vitro enzymatic colorimetric kit for quantification of nonesterified fatty acids (NEFA C, Wako Diagnostics, Richmond, VA), using the microtiter procedure. All NEFA assays were done in 4 runs. The intraassay CV was 2.4%, and the interassay CV was 4.5%.

HR During Transport Heart rate was also measured during transportation to the campus slaughter facility. Transportation took place on 8 separate mornings, with 24 pigs being transported daily from 4 of the pens. Due to equipment constraints, the HR of only 8 pigs was recorded each day. Thus, a total of 64 pigs were recorded (2 pigs recorded from each of the 32 pens). On transport days, the 8 selected pigs (2 per treatment) were fitted with HR monitors, with the transmitter belt and receivers then entirely covered with Vetrap (3M, 3M Center, St. Paul, MN) to prevent the equipment being damaged by other pigs during transport. Once the monitors had been fitted, the 8 pigs with monitors were released into the central corridor, together with the other 4 pigs from the control treatment, because all control pigs had to go through the slaughter line before any were treated with an experimental drug. They were herded down the corridor onto a hydraulic trailer lowered to floor level, situated in the central handling room between the 2 wings of the Evaluation Center. Once the 12 pigs were on the trailer, it was raised and pulled 20 m outside to a flatbed truck. The pigs were then herded off the trailer onto the truck and transported to the slaughter facility, after stopping to pick up a single pig elsewhere on the farm. Once at the slaughter facility, pigs were off-loaded straight into a lairage room, and the HR equipment was removed. The HR data were downloaded as above and were analyzed to determine mean HR every 1 min over the loading, transport, and unloading periods, in bpm, with each pig as an experimental unit.

Statistical Analysis

The experiment was a repeated measure design with repeated measurements of animals (main units) over time (subunits). Handling behavior data, human presence test behavior data, human presence test HR, and transport HR data were analyzed using the repeated option of PROC GLM (SAS Inst. Inc., Cary, NC). Dietary drug treatment, time, sex, time x treatment, and sex x treatment interactions were included in the model. In terms of the blood parameters, data for wk 0 to 4 were analyzed together using a repeated ANOVA with wk 0 as a covariate. Postslaughter data were analyzed separately, because these data represented the difference in the 24-h or 48-h withdrawal. Data were transformed as appropriate when the assumption of normality was not fulfilled (Sokal and Rohlf, 1981Go). Data expressed as proportions (for example, proportions of observations) were transformed using arcsine-root transformation. Count data were transformed using logarithmic transformation.


    RESULTS
 Top
 Abstract
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Two pigs died during the experimental period (both with pneumonia as the primary cause of death). One pig was from the 2R-salbutamol treatment, and 1 pig was from the 4R-salbutamol treatment. Thus, the data presented are from 190 pigs.

Behavior in the Home Pen

In terms of location, 4R pigs spent a lesser proportion of total time (P < 0.01) at the back of the pen than 2R pigs or 8RS pigs (Table 5Go). There were no effects of treatment on the proportion of time spent in the middle or front of the pen. In terms of postures, there were no treatment effects (P > 0.14) on proportion of time spent standing, lying sternally, or lying laterally, but there were treatment effects (P < 0.02) on the proportion of time spent sitting (Table 5Go) and the amount of time spent kneeling (Table 5Go), with 2R pigs spending less time in both postures than 4R and 8RS pigs.


View this table:
[in this window]
[in a new window]

 
Table 5. Mean proportion of time spent in various locations and postures by finishing pigs on salbutamol-added or control diets
 
No treatment effect was observed on proportion of time spent inactive (P = 0.12), but 2R pigs spent less time alert (P < 0.05, Figure 1aGo) than 4R pigs. Control pigs spent less time rooting than 4R and 8RS pigs (P < 0.001, Figure 2aGo), and 2R pigs spent less time drinking than 8RS pigs (P < 0.05, Figure 2bGo). The 2R pigs were seen belly nosing more often than 4R pigs (P < 0.01, Figure 1bGo), and tail-biting was observed more often than control and 8RS pigs (P < 0.05, Figure 2cGo). There were no treatment effects (P > 0.26) on either scan-sampled aggression (Figure 2dGo) or all-occurrences-sampled aggression or on positive social behavior.


Figure 1
View larger version (22K):
[in this window]
[in a new window]

 
Figure 1. Mean + SE proportion of time that pigs spent engaged in various behaviors compared by dietary treatment ({square}): a) the mean + SE proportion of time spent alert, b) the mean + SE proportion of time spent belly nosing; and compared by sampling period ({blacksquare}): c) the mean + SE proportion of time spent inactive and d) the mean + SE proportion of time spent walking. a–cBars lacking a common letter differ (P < 0.05). CTL = control; 2R = 2 mg/kg of R-salbutamol; 4R= mg/kg of R-salbutamol; 8RS = 8 mg/kg of RS-salbutamol.

 

Figure 2
View larger version (39K):
[in this window]
[in a new window]

 
Figure 2. Mean + SE proportion of time that pigs of 4 different dietary treatments spent engaged in various behaviors over 24-h periods including a) the mean + SE proportion of time spent rooting, b) the mean + SE proportion of time spent drinking, c) the mean + SE proportion of time spent tail-biting, and d) the mean + SE proportion of time spent engaged in aggression. Dietary treatments are control diet ({blacksquare}), 2 mg/kg of R-salbutamol (dark gray), 4 mg/kg of R-salbutamol (light gray), and 8 mg/kg of RS-salbutamol ({square}). TRT = dietary treatment effects; TIME = sampling period effects; and TRT x TIME = interaction of the main effects; NS = not significant.

 
There were several time effects on behavior. Over the course of the 4-wk experimental period, pigs spent an increasing proportion of time in the front of the pen (P < 0.001, Table 5Go) and decreasing proportions of time in the middle (P < 0.001, Table 5Go) and back of the pen (P < 0.001, Table 5Go). In terms of postures, pigs spent decreasing proportions (P < 0.001, Table 5Go) of time standing and lying sternally and increasing proportions (P < 0.01, Table 5Go) of time sitting and lying laterally. In terms of specific behaviors, pigs engaged in increasing amounts of inactivity over time (P < 0.001, Figure 1cGo), with decreasing proportions (P < 0.001) of time spent rooting and eating. The proportion of time spent walking was greatest in wk 2 (Figure 1dGo), and pigs spent an increasing proportion (P < 0.01, Figure 2bGo) of time drinking.

Female pigs spent more time standing (P = 0.001) and less time sitting (P < 0.05) than male pigs and tended to spend less time lying laterally (P < 0.10). Female pigs also spent more time (P < 0.001) walking and rooting than male pigs.

Behavior During Handling

Overall, no treatment effects were observed (P > 0.34) on the number of pigs exiting the home pen voluntarily (CTL = 2.5 ± 0.2; 2R = 2.2 ± 0.2; 4R = 2.1 ± 0.2; 8RS = 2.6 ± 0.2), the time taken to exit the home pen (CTL = 23.8 ± 1.7 s; 2R = 25.1 ± 1.1 s; 4R = 27.3 ± 1.2 s; 8RS = 23.5 ± 1.4 s), the time taken to get the pig onto the weigh scale (CTL = 9.5 ± 0.5 s; 2R = 10.0 ± 0.5 s; 4R = 9.3 ± 0.4 s; 8RS = 9.3 ± 0.5 s), and the total number of physical interactions needed to get the pig onto the weigh scale (CTL = 2.6 ± 0.2; 2R = 3.0 ± 0.3; 4R = 2.6 ± 0.2; 8RS = 2.9 ± 0.3). Similarly, there were no treatment effects observed (P > 0.19) on the time taken to get the pig off the weigh scale (CTL = 3.6 ± 0.1 s; 2R = 4.0 ± 0.1 s; 4R = 3.8 ± 0.1 s; 8RS = 3.9 ± 0.1 s), the total number of physical interactions needed to get the pig off the weigh scale (CTL = 1.4 ± 0.1; 2R = 1.4 ± 0.1; 4R = 2.6 ± 0.1; 8RS = 1.4 ± 0.1), or the time taken to get the pigs back into the home pen (CTL = 24.6 ± 1.9 s; 2R = 23.2 ± 1.2 s; 4R = 21.8 ± 1.3 s; 8RS = 25.4 ± 1.7 s). Within given weeks, there were very few differences between treatments and no consistency across weeks.

No sex effects were observed in any of the variables measured, but there were several time effects. First, there was a tendency (P < 0.10) for more pigs to leave the pen voluntarily as the experimental period progressed (Figure 3aGo), but this did not affect the total amount of time taken for all pigs to exit the home pen. The amount of time taken to get pigs onto the scale did not vary over the experimental period, but it took increasingly more physical interactions from the handler (P < 0.001) to get the pigs onto the scale (Figure 3bGo). Once weighed, pigs needed an increasing number of physical interactions from the handler (P < 0.001, Figure 3cGo), and it took increasingly more time (P = 0.01) to get all the pigs back into the home pen (Figure 3dGo).


Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
Figure 3. Mean + SE of measures associated with handling compared by sampling period ({blacksquare}), including a) the mean + SE number of pigs exiting the home pen voluntarily, b) the mean + SE number of physical interactions applied by the handler to get the pig onto the weigh scale, c) the mean + SE number of physical interactions applied by the handler to get the pig off the weigh scale, and d) the mean + SE time taken to get all pigs back into the home pen. a–cBars lacking a common letter differ (P < 0.05), x,yBars lacking a common letter differ (P < 0.10).

 
Human Presence Test—Heart Rate

In the week before implementation of the experimental diets, no treatment differences were observed (P > 0.10) in either overall mean HR (CTL = 145.7 ± 3.1 bpm; 2R = 146.7 ± 3.4 bpm; 4R = 146.3 ± 4.0 bpm; 8RS = 145.0 ± 2.9 bpm) or in mean HR at any of the 1-min time periods (Figure 4aGo). By wk 1, however, control pigs had less HR (P < 0.01) than pigs in all 3 treatments (CTL = 141.8 ± 2.2 bpm; 2R = 149.5 ± 1.7 bpm; 4R = 151.3 ± 2.3 bpm; 8RS = 153.5 ± 2.3 bpm). All 1-min time periods were also different except for the first minute compared with 4R pigs (Figure 4bGo). Control treatment pigs also had less HR (P < 0.06) during wk 3 than pigs in all 3 treatments (CTL = 138.8 ± 1.9 bpm; 2R = 148.5 ± 2.8 bpm; 4R = 146.5 ± 2.8 bpm; 8RS = 152.5 ± 3.0 bpm). Heart rates during 1-min time periods from the first to the eighth minute were mostly less in control pigs compared with the other 3 treatments (Figure 4cGo), but in min 9 and 10, there were no differences between treatments (P > 0.10).


Figure 4
View larger version (29K):
[in this window]
[in a new window]

 
Figure 4. Mean ± SE heart rate responses of pigs from 4 dietary treatments over each 1-min period within a 10-min human presence in the home pen during a) wk 0, b) wk 1, and c) wk 3. R = R-salbutamol; RS = RS-salbutamol.

 
With repeated measures across all 3 wk, a strong tendency was noted for CTL pigs to have less HR (P = 0.05). There was no sex effect (P = 0.62), but there was a tendency for a time effect (P = 0.07) and a time x treatment interaction (P = 0.03).

Human Presence Test—Behavior

In terms of behavior, no differences were observed (P > 0.10) between treatments in any of the variables measured. Most importantly, there were no treatment differences (P > 0.73) in the proportion of time that pigs spent either in contact with the human (CTL = 0.15 ± 0.03; 2R = 0.15 ± 0.02; 4R = 0.17 ± 0.02; 8RS = 0.15 ± 0.02), with their head and shoulders positioned in the third of the pen nearest to the human (CTL = 0.17 ± 0.02; 2R = 0.15 ± 0.01; 4R = 0.15 ± 0.01; 8RS = 0.14 ± 0.01), or purposefully interacting with the human (CTL = 0.14 ± 0.02; 2R = 0.15 ± 0.02; 4R = 0.14 ± 0.02; 8RS = 0.14 ± 0.02). There were also no treatment differences (P = 0.67) in the amount of aggressive social behavior.

The only sex differences were in the postural categories, with gilts spending more time standing (0.84 ± 0.02 vs. 0.75 ± 0.03, P = 0.01) and barrows spending more time sitting (0.04 ± 0.01 vs. 0.02 ± 0.01, P = 0.01) and tending to spend more time (P < 0.09) lying sternally and lying laterally. Several behaviors changed over time. Overall, pigs spent more time (P < 0.01) in contact with the human (Figure 5aGo) and interacting with the human over time (Figure 5bGo). They also tended to spend more time with their head and shoulders in the third nearest the human (P = 0.06) and spent less time with their head and shoulders in the farthest part of the pen (P < 0.001, Figure 5cGo). Time spent alert (Figure 5dGo), time spent walking (Figure 5eGo), and time spent engaged in positive social interactions (Figure 5fGo) all decreased over time (P < 0.04).


Figure 5
View larger version (30K):
[in this window]
[in a new window]

 
Figure 5. Mean + SE proportion of time that pigs spent engaged in various behaviors during the 10-min human presence test in the home pen compared by sampling period ({blacksquare}), including a) the mean + SE proportion of time spent in contact with the person, b) the mean + SE proportion of time spent actively interacting with the person, c) the mean + SE proportion of time spent far from the person, d) the mean + SE proportion of time spent alert, e) the mean + SE proportion of time spent walking, and f) the mean + SE proportion of time spent engaged in positive social interaction. a,bBars lacking a common letter differ (P < 0.05).

 
Blood Physiology

From the repeated measures analysis performed on wk 0, 2, and 4 blood samples, treatment differences were observed (P < 0.02) in concentrations of CK (Figure 6aGo), with CTL pigs having less CK concentrations than pigs on all 3 salbutamol treatments, and BUN (Figure 6bGo), with CTL pigs having greater BUN concentrations than pigs on all 3 salbutamol treatments. There were also tendencies (P < 0.08) for CTL pigs to have lesser insulin concentrations than pigs on the other 3 treatments (CTL = 1.79 ± 0.25 µIU/mL; 2R = 2.36 ± 0.24 µIU/mL; 4R = 2.64 ± 0.50 µIU/mL; 8RS = 2.43 ± 0.25 µIU/mL) and for 2R and 4R pigs to have greater ammonia concentrations than CTL and 8RS pigs (CTL = 17.6 ± 2.4 µmol/L; 2R = 25.0 ± 3.0 µmol/L; 4R = 22.2 ± 3.0 µmol/L; 8RS = 17.4 ± 2.4 µmol/L). There were no treatment differences (P > 0.29) in circulating epinephrine concentrations (CTL = 140 ± 30 pg/mL; 2R = 212 ± 58 pg/mL; 4R = 199 ± 50 pg/mL; 8RS = 160 ± 28 pg/mL), norepinephrine concentrations (CTL = 886 ± 154 pg/mL; 2R = 1,307 ± 259 pg/mL; 4R = 1,086 ± 159 pg/mL; 8RS = 1,130 ± 262 pg/mL), or lactate concentrations (CTL = 8.4 ± 1.0 mM/mL; 2R = 6.2 ± 0.5 mM/mL; 4R = 6.1 ± 0.6 mM/mL; 8RS = 10.0 ± 1.1 mM/mL). There were sex effects (P < 0.02) for CK and BUN with barrows having greater concentrations than gilts and treatment x sex interactions for insulin (Figure 6cGo) and cortisol (Figure 6dGo). The only significant time effect (P < 0.01) was with ammonia concentrations, which showed a peak during wk 2.


Figure 6
View larger version (32K):
[in this window]
[in a new window]

 
Figure 6. Mean + SE plasma concentrations of a) creatine kinase and b) blood urea nitrogen of pigs compared by treatment and time. Dietary treatments are control diet ({blacksquare}), 2 mg/kg of R-salbutamol (dark gray), 4 mg/kg of R-salbutamol (light gray), and 8 mg/kg of RS-salbutamol ({square} ). TRT = dietary treatment effects; TIME = sampling period effects; TRT x TIME = interaction of the main effects; and NS = not significant. Mean + SE plasma concentrations of c) insulin and d) cortisol of pigs from 4 different dietary treatments compared by sex and treatment. Sexes are female ({blacksquare}) and male ({square}). TRT = dietary treatment effects; SEX = sex effects; TRT x SEX = interaction of the main effects; and NS = not significant.

 
From the separate analysis of the postslaughter samples, there were no treatment differences (P > 0.10) for any of the compounds measured. There was also no effect (P > 0.10) of withdrawal time on any of the measures. There was a sex effect for concentrations of BUN (P = 0.02), with barrows having greater concentrations than gilts.

HR During Transport

No treatment effects were observed (P > 0.14) on overall HR during loading, transport, or unloading. However, there was a treatment effect (P = 0.02) on the peak or maximum HR recorded over the whole journey process, with 2R pigs having less peak HR (212.5 ± 7.9 bpm) than CTL pigs (234.8 ± 3.6 bpm) or 8RS pigs (232.3 ± 3.1 bpm). Treatment effects were also observed (P < 0.05) at some 1-min time points during the transport phase of the journey. At 4, 5, and 6 min and again between 18 and 24 min, CTL pigs had greater HR than pigs on the 3 salbutamol treatments (Figure 7Go). They also had greater HR during the fifth minute of unloading (Figure 7Go).


Figure 7
View larger version (20K):
[in this window]
[in a new window]

 
Figure 7. Mean ± SE heart rate of pigs from 4 different dietary treatments undergoing a journey, which includes a 5-min loading period (L1 to L5), a 26-min transportation period (T1 to T26), and a 5-min unloading period (U1 to U5). CTL = control; 2R = 2 mg/kg of R-salbutamol; 4R = 4 mg/kg of R-salbutamol; 8RS = 8 mg/kg of RS-salbutamol.

 
Not surprisingly, time effects were observed over each of the phases of the journey. Heart rates increased (P < 0.001) during loading (Figure 7Go), decreased over transport (P < 0.001, Figure 7Go), and increased again over unloading (P < 0.001, Figure 7Go). Overall, there were no sex effects and no effects of withdrawal time (P > 0.10).


    DISCUSSION
 Top
 Abstract
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Overall, salbutamol had some effects on behavior and physiology of finishing pigs, relative to those on control diets. Effects were varied depending on situation, salbutamol concentration, and time on diet. Dietary treatment did not have a large effect on home pen behavior. Salbutamol did not affect time spent active, time spent alert, or time spent lying laterally. In rats, salbutamol has been shown to decrease locomotor behavior (O’Donnell, 1993aGo), as have other β-agonists such as clenbuterol (O’Donnell, 1993bGo), isoproterenol (O’Donnell, 1993bGo), and zinterol (O’Donnell, 1993cGo). In swine, the β-agonist ractopamine had the opposite effect and increased both activity and time spent alert while decreasing time spent lying laterally (Marchant-Forde et al., 2003Go).

There was some evidence of increased belly nosing and tail-biting in the 2R-salbutamol treatment, but these results must be viewed with extreme caution, because these behaviors are very short in duration and very low in incidence and thus not best suited to being robustly detected by scan sampling. Also, the incidence of belly nosing was already greater in the 2R-salbutamol pigs before going onto the dietary treatment, and the incidence of tail-biting shows no consistent pattern. Although tail-biting was observed, it had no clinical implications and did not need intervention.

No overall treatment effects were noted on handling parameters at any time during the experimental period. Pigs on all treatments became increasingly willing to exit the home pen and did not take longer to get onto or off the weigh scale over time. This is in contrast to results observed by Marchant-Forde et al. (2003)Go in a study of ractopamine-fed pigs, who became less willing to leave the home pen voluntarily and who took approximately twice as long to weigh as pigs on a control diet. Ractopamine-fed pigs also took more physical interactions from the handlers to complete the weighing process (Marchant-Forde et al., 2003Go). In the current study, all pigs were subjected to more physical interactions over time, making them increasingly difficult to handle. However, there were clear differences in willingness between the 2 experiments, and the fact that pigs in the current experiment needed more interactions was probably more due to the fact that they had become habituated to the weighing process and to the handler. Although fearfulness has been demonstrated to negatively affect ease of handling (Hemsworth, 2003Go), lack of fear can also make animals harder to handle (Grandin, 1987Go; Marchant-Forde, 2002Go). Pigs that are comfortable around humans can exhibit a negative flight zone and consequently take longer to move (McGlone and Pond, 2003Go).

The human presence test was also essentially a measure of the fearfulness of pigs of humans. The behavior results support the hypothesis that the pigs became less fearful over time. Results clearly show that pigs in all treatments spent increasing amounts of time in contact with or directly interacting with the human and less time in the third of the pen farthest away from the human. Again, no effect of treatment was observed. Treatment did affect HR during this test, with salbutamol-treated pigs having HR values between 8 to 12 bpm greater than control pigs. These results are similar to those observed in ractopamine-fed pigs (Marchant-Forde et al., 2003Go), which had HR of 8 bpm greater than control pigs. Nebulized administration of levalbuterol and racemic salbutamol is known to induce tachycardia in humans (Lam and Chen, 2003Go), and because there were no treatment differences in activity to account for the HR changes, the conclusion would be that this increase is pharmacological in nature. It was originally thought that the effect on HR was as a result of direct stimulation of β1 cardiac receptors or a baroreceptor-mediated reflex due to vasodilation and leading to a release in norepinephrine (Simonsson et al., 1972Go). However, salbutamol has more recently been shown to affect HR by a direct action on cardiac β2 receptors (Insulander et al., 2004Go). In humans with asthma and chronic obstructive pulmonary disease, the cardiovascular effects of salbutamol have been implicated in an increased risk of spontaneous arrhythmias (Kallergis et al., 2005Go) and even sudden death (Salpeter et al., 2004Go). Many of these data are derived from studies ranging in dosing length from 3 mo to 1 yr. There are no comparable data from healthy subjects taking repeated doses over 4 or more weeks. The clinical or welfare implications of the increased HR noted in our study are therefore unknown.

No treatment effect was observed on catecholamine or cortisol concentrations. Orally administered salbutamol given over 2 wk had no effect on epinephrine concentrations in humans (Warren et al., 1983Go). Also, salbutamol fed at 3 mg/kg has been shown to result in increased ACTH concentrations in 50-kg pigs after acute stress in behavioral tests (Jensen et al., 1994Go). These results indicate that salbutamol does not affect sympathetic-adrenal-medullary or hypothalamic-pituitary-adrenal axes activity. In contrast, ractopamine given orally over 4 wk to swine resulted in increased plasma epinephrine and norepinephrine concentrations (Marchant-Forde et al., 2003Go). Salbutamol-treated pigs had greater concentrations of CK and lesser concentrations of BUN, indicating increased protein accretion results and consistent with those observed with ractopamine (See et al., 2004Go). There was no treatment effect on plasma lactate concentrations, which is in contrast to results published elsewhere, showing that administration of salbutamol increased plasma lactate concentrations (Oksbjerg et al., 1996Go), as did clenbuterol (Baldi et al., 1994Go). Elevated plasma lactate concentrations have been implicated elsewhere in the issue of downer pigs (Anderson et al., 2002Go), with data suggesting that the downer pig is in a state of metabolic acidosis. Plasma lactate concentrations are known to be elevated in response to aggressive handling (Anderson et al., 2002Go; Hamilton et al., 2004Go), and a previous study showed that ractopamine made pigs harder to handle (Marchant-Forde et al., 2003Go) and thus potentially more at risk of being subject to aggressive handling.

In contrast to the human presence test results in this study, control pigs had greater HR during the transport process. In a previous study, control pigs had less HR response to transport than ractopamine-fed pigs (Marchant-Forde et al., 2003Go). One major difference in methodology of studies that may influence this difference is that of withdrawal. In the current study, pigs were withdrawn from salbutamol either 24 or 48 h before transport. Ractopamine-fed pigs in Marchant-Forde et al. (2003)Go had no withdrawal period. Another issue to consider is the design of the transport section of the study, which was confounded to some extent by meat hygiene regulations. On the first truckload to the slaughter plant, we had to accommodate all control pigs that were being killed that day, because they had to be slaughtered first. This truck therefore contained 6 CTL pigs (2 with HR monitors), two 2R pigs (with monitors), two 4R pigs (with monitors), and two 8RS pigs (with monitors). Thus, each control pig traveled with 6 nonpenmates, whereas each salbutamol pig traveled with 10 nonpenmates. Subsequent to loading, a single pig from another experiment was loaded at between 3 and 5 min. When unfamiliar pigs are mixed, they engage in agonistic behavior, and this behavior can induce increased HR (Marchant et al., 1995Go). We should therefore expect that salbutamol-treated pigs were subjected to greater degrees of social stress, because they were mixed with many more unfamiliar animals. In this study, we saw the opposite; control pigs had greater HR. Also, when the single pig was mixed, this clearly induced a cardiac response in control pigs but not in the salbutamol-treated pigs. Further research is necessary to explain these results.

Overall, results from this study appear to demonstrate that R-salbutamol fed at 2 and 4 mg/kg and R-S-salbutamol fed at 8 mg/kg have few effects on behavior and physiology of finishing pigs, when fed over a 4-wk period. Although HR may be increased by salbutamol during testing in the home pen, HR response to transport, after 24 or 48 h of withdrawal, is actually decreased relative to control.


    Footnotes
 
1 This work was partly supported by Stirling Products Ltd., Perth, Australia, and we are grateful to C. London and M. Sadler for their input on experimental design. We thank J. Emilson, R. Byrd, and the other Purdue Animal Sciences Research and Education Center Swine Unit staff for technical assistance. We also thank USDA-ARS technicians G. Nowling, S. Peterson, K. Pohle, and L. Hasenour for help with data collection and analysis. Back

2 The use of a trade, firm, or corporation in this publication is for the information and convenience of the reader. Such use does not constitute an official endorsement or approval by the USDA or ARS of any product or service to the exclusion of others that may be suitable. Back

4 Present address: School of Veterinary Medicine, Purdue University, West Lafayette, IN 47907. Back

3 Corresponding author: jeremy.marchant-forde{at}ars.usda.gov

Received for publication March 31, 2008. Accepted for publication May 22, 2008.


    LITERATURE CITED
 Top
 Abstract
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 


Anderson, D. B., D. J. Ivers, M. E. Benjamin, H. W. Gonyou, D. J. Jones, K. D. Miller, R. K. McGuffey, T. A. Armstrong, D. H. Mowrey, L. F. Richardson, R. Seneriz, J. R. Wagner, L. E. Watkins, and A. G. Zimmermann. 2002. Physiological responses of market hogs to different handling practices. Proc. Am. Assoc. Swine Vet., Kansas City, MO.

Baldi, A., V. Bontempo, F. Cheli, C. Corino, and F. Polidori. 1994. Hormonal and metabolic responses to the stress of transport and slaughterhouse procedures in clenbuterol-fed pigs. J. Vet. Med. Ser. A Physiol. Pathol. Clin. Med. 41:189–196.

FASS. 1999. Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. 1st rev. ed. Fed. Anim. Sci. Soc., Savoy, IL.

FDA. 2002. Freedom of Information Summary. http://www.fda.gov/cvm/FOI/140-863.pdf Accessed March 28, 2008.

Grandin, T. 1987. Animal handling. Vet. Clin. North Am. Food Anim. Pract. 3:323–338.[Medline]

Gu, Y., A. P. Schinckel, J. C. Forrest, C. H. Kuei, and L. E. Watkins. 1991a. Effects of ractopamine, genotype and growth phase on finishing performance and carcass value in swine: I. Growth performance and carcass merit. J. Anim. Sci. 69:2685–2693.[Abstract]

Gu, Y., A. P. Schinckel, J. C. Forrest, C. H. Kuei, and L. E. Watkins. 1991b. Effects of ractopamine, genotype, and growth phase on finishing performance and carcass value in swine: II. Estimation of lean growth rate and lean feed efficiency. J. Anim. Sci. 69:2694–2702.[Abstract]

Hamilton, D. N., M. Ellis, T. M. Bertol, and K. D. Miller. 2004. Effects of handling intensity and live weight on blood acid-base status in finishing pigs. J. Anim. Sci. 82:2405–2409.[Abstract/Free Full Text]

Hansen, J. A., J. T. Yen, J. Klindt, J. L. Nelssen, and R. D. Goodband. 1997. Effects of somatotropin and salbutamol in three genotypes of finishing barrows: Blood hormones and metabolites and muscle characteristics. J. Anim. Sci. 75:1810–1821.[Abstract/Free Full Text]

Hemsworth, P. H. 2003. Human-animal interactions in livestock production. Appl. Anim. Behav. Sci. 81:185–198.[CrossRef]

Hill, M. A., and R. H. Dalrymple. 1987. Evaluation of feet and skeletons of limbs from pigs treated with a repartitioning agent, cimaterol. Can. J. Vet. Res. 51:217–223.[Medline]

Insulander, P., A. Juhlin-Dannfelt, U. Freyschuss, and H. Vallin. 2004. Electrophysiologic effects of salbutamol, a β2-selective agonist. J. Cardiovasc. Electrophysiol. 15:316–322.[Medline]

Jensen, K. H., N. Oksbjerg, and E. Jorgensen. 1994. Dietary salbutamol and level of protein – Effects on the acute stress response in pigs. Physiol. Behav. 55:375–379.[CrossRef][Medline]

Kallergis, E. M., E. G. Manios, E. M. Kanoupakis, S. E. Schiza, H. E. Mavrakis, N. K. Klapsinos, and P. E. Vardas. 2005. Acute electrophysiologic effects of inhaled salbutamol in humans. Chest 127:2057–2063.[CrossRef][Medline]

Lam, S., and J. Chen. 2003. Changes in heart rate associated with nebulized racemic salbutamol and levalbuterol in intensive care patients. Am. J. Health Syst. Pharm. 60:1971–1975.[Abstract/Free Full Text]

Marchant, J. N., M. T. Mendl, A. R. Rudd, and D. M. Broom. 1995. The effect of agonistic interactions on heart rate of group-housed sows. Appl. Anim. Behav. Sci. 46:49–56.[CrossRef]

Marchant-Forde, J. N. 2002. Piglet- and stockperson-directed sow aggression after farrowing and the relationship with a pre-farrowing human approach test. Appl. Anim. Behav. Sci. 75:115–132.[CrossRef]

Marchant-Forde, J. N., D. C. Lay Jr, B. T. Richert, A. P. Schinckel, and E. A. Pajor. 2003. The effects of ractopamine on behavior and physiology of finishing pigs. J. Anim. Sci. 81:416–422.[Abstract/Free Full Text]

McGlone, J. J., and W. G. Pond. 2003. Pig Production: Biological Principles and Applications. Thomson Delmar Learning, Clifton Park, NY.

Moser, R. L., R. H. Dalrymple, S. G. Cornelius, J. E. Pettigrew, and C. E. Allen. 1986. Effect of cimaterol (CL 263,780) as a repartitioning agent in the diet for finishing pigs. J. Anim. Sci. 62:21–26.[Abstract/Free Full Text]

O’Donnell, J. M. 1993a. Differential sensitivity to the effects of salbuterol on locomotor-activity and operant-behavior. Psychopharmacology (Berl.) 113:243–249.[CrossRef][Medline]

O’Donnell, J. M. 1993b. Reduced locomotor-activity of rats mediated by peripheral β-adrenergic receptors. Res. Commun. Chem. Pathol. Pharmacol. 82:375–378.[Medline]

O’Donnell, J. M. 1993c. Effects of the β-2-adrenergic agonist zinterol on DRL behavior and locomotor-activity. Psychopharmacology (Berl.) 113:89–94.[CrossRef][Medline]

Oksbjerg, N., J. A. Fernandez, H. Jorgensen, O. H. Olsen, T. Rolph, and N. Agergaard. 1996. Effects of salbutamol on protein and fat deposition in pigs fed two levels of protein. J. Anim. Physiol. Anim. Nutr. (Berl.) 75:1–12.

Ricks, C. A., P. K. Baker, R. H. Dalrymple, M. E. Doscher, D. L. Ingle, and J. Pankavich. 1984. Use of clenbuterol to alter muscle and fat accretion in swine. Fed. Proc. 43:857. (Abstr.)

Salleras, L., A. Dominguez, E. Mata, J. L. Taberner, I. Moro, and P. Salva. 1995. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep. 110:338–342.

Salpeter, S. R., T. M. Ormiston, and E. E. Saltpeter. 2004. Cardiovascular effects of β-agonists in patients with asthma and COPD. Chest 125:2309–2321.[CrossRef][Medline]

Schinckel, A. P., N. Li, B. T. Richert, P. V. Preckel, and M. E. Einstein. 2003. Development of a model to describe the compositional growth and dietary lysine requirements of pigs fed ractopamine. J. Anim. Sci. 81:1106–1119.[Abstract/Free Full Text]

See, M. T., T. A. Armstrong, and W. C. Weldon. 2004. Effect of a ractopamine feeding program on growth performance and carcass composition in finishing pigs. J. Anim. Sci. 82:2474–2480.[Abstract/Free Full Text]

Simonsson, B. G., J. Stiksa, and B. Strom. 1972. Double-blind trial with increasing does of salbutamol and terbutaline aerosols in patients with reversible airway obstruction. Acta Med. Scand. 192:371–376.[Medline]

Sokal, R. R., and F. J. Rohlf. 1981. Biometry. 2nd ed. Freeman, San Francisco, CA.

Warren, J. B., N. Dalton, and C. Turner. 1983. Effect of a 2-wk course of oral salbutamol on adrenomedullary function in normal subjects. Br. J. Clin. Pharmacol. 15:67–70.[Medline]

Watkins, L. E., D. J. Jones, D. H. Mowrey, D. B. Anderson, and E. L. Veenhuizen. 1990. The effect of various levels of ractopamine hydrochloride on the performance and carcass characteristics of finishing swine. J. Anim. Sci. 68:3588–3595.[Abstract]

Williams, N. H., T. R. Cline, A. P. Schinckel, and D. J. Jones. 1994. The impact of ractopamine, energy intake and dietary fat on finisher pig growth performance and carcass merit. J. Anim. Sci. 72:3152–3162.[Abstract]



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jas.2008-1075v1
86/11/3110    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchant-Forde, J. N.
Right arrow Articles by Richert, B. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchant-Forde, J. N.
Right arrow Articles by Richert, B. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS